Prudential PLC Moderna, Inc. Transaction History

Prudential PLC

$19.6 Billion
Q3 2024

A detailed history of Prudential PLC transactions in Moderna, Inc. stock. As of the latest transaction made, Prudential PLC holds 5,488 shares of MRNA stock, worth $223,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,488

Previous 5,488 -0.0%

Holding current value

$223,690

Previous $651,000 43.78%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $386,811 - $523,058	-4,531 Reduced 45.22%	5,488 $584,000
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $695 - $1,044	10 Added 0.1%	10,019 $996,000
Q3 2023 Nov 09, 2023	SELL	$96.41 - $126.61 $117,138 - $153,831	-1,215 Reduced 10.83%	10,009 $1.03 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $7,347 - $9,952	-62 Reduced 0.55%	11,224 $1.36 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $3,120 - $4,531	23 Added 0.2%	11,286 $1.73 Million
Q4 2022 Feb 08, 2023	SELL	$118.38 - $210.04 $476,124 - $844,780	-4,022 Reduced 26.31%	11,263 $2.02 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $678,784 - $1.12 Million	5,749 Added 60.29%	15,285 $1.81 Million
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $75,080 - $113,194	641 Added 7.21%	9,536 $1.36 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $721,580 - $1.34 Million	5,706 Added 178.93%	8,895 $1.53 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $720,139 - $1.18 Million	3,189 New	3,189 $810,000
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $1.89 Million - $3.41 Million	-14,515 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $1.58 Million - $2.7 Million	14,515 New	14,515 $1.9 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account